Abstract
No public abstract is available from the verified source records.
Carlota López Domínguez, Alejandra García Novoa, Benigno Acea Nebril, Sergio Rodríguez Rojo, Aloia Guerreiro Caamaño
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Omission of sentinel node biopsy for breast cancer: Historical context and future perspectives on a modern controversy
10.1002/cncr.33960 · 2021
Use of sentinel lymph node biopsy in elderly patients with breast cancer – 10-year experience from a Swiss university hospital
10.1186/s12957-023-03062-1 · 2023
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy total mastectomy, and total mastectomy followed by irradiation
10.1056/nejmoa020128 · 2002
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial
10.1200/jco.22.01565 · 2023
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
10.1016/s1470-2045(18)30380-2 · 2018
Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial
10.1001/jama.2017.11470 · 2017
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
10.1001/jama.2013.278932 · 2013
The impact of genomic profiling on adjuvant therapy recommendation in postmenopausal women with ER-positive, T1-2 breast cancer: can genomic profiling eliminate the need for sentinel lymph node biopsy?
openalex
Confidence 95%
datacite
Confidence 0%
10.1016/j.clbc.2021.02.011 · 2021
De-escalating axillary surgery in early-stage breast cancer
10.1016/j.breast.2021.11.018 · 2022
Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR+ breast cancer and negative axillary ultrasound
10.1007/s10549-020-05768-2 · 2020
Impact of sentinel lymph node biopsy on management of older women with clinically node-negative, early-stage, ER+/HER2− invasive breast cancer: a systematic review and meta-analysis
10.1016/j.clbc.2024.07.012 · 2024
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate helath care interventions: explanation and elaboration
2009
Prevalence of pathologic N2/N3 disease in postmenopausal women with clinical N0 ER+/HER2− breast cancer
10.1245/s10434-022-12056-4 · 2022
Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer
10.1002/cncr.32668 · 2020
Axillary staging is not justified in postmenopausal clinically node-negative women based on nodal disease burden
10.1245/s10434-022-12203-x · 2023
The role of routine sentinel lymph node biopsy in elderly patients with breast cancer
10.1016/j.ejso.2022.03.094 · 2022
Abstract P2-14-07: Omission of sentinel lymph node biopsy in patients with early stage breast cancer: looking beyond the choosing wisely guidelines for age<70
2023
Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the sound randomized clinical trial
10.1001/jamaoncol.2023.3759 · 2023
Axillary surgery in breast cancer - Primary results of the INSEMA trial
10.1056/nejmoa2412063 · 2025
Omitting radiotherapy is safe in breast cancer patients≥70 years old after breast-conserving surgery without axillary lymph node operation
10.1038/s41598-020-76663-5 · 2020
Omission of radiotherapy in women>60 years old after breast conserving surgery for breast cancer is non-inferior in terms of local recurrence: a retrospective cohort study
10.4274/ejbh.galenos.2023.2023-9-5 · 2024
Long-term outcome of pT1a-b, cN0 breast cancer without axillary dissection or staging: a prospective observational study of 1543 women
10.1002/bjs.11610 · 2020
Outcomes after sentinel lymph node biopsy and radiotherapy in older women with early-stage estrogen receptor-positive breast cancer
10.1001/jamanetworkopen.2021.6322 · 2021
Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative estrogen receptor-positive breast cancer
10.3747/co.27.6515 · 2020
Can we successfully de-escalate axillary surgery in women aged≥70 years with ductal carcinoma in situ or early-stage breast cancer undergoing mastectomy?
10.1245/s10434-021-11140-5 · 2022
The role of sentinel lymph node biopsy in planning adjuvant therapy for elderly women with low-risk breast cancer
10.1111/tbj.13577 · 2020
O79: The role of sentinel lymph node biopsy in breast cancer patients over the age of 80 – How much is enough?
2021
Impact of sentinel lymph node biopsy on treatment decision and survival in patients aged≥70 years with breast cancer: a retrospective study
10.1177/15330338221137216 · 2022
(P05) Does sentinel lymph node biopsy impact systemic therapy recommendations?
10.1016/j.ijrobp.2018.02.093 · 2018
Does sentinel lymph node biopsy influence subsequent management decisions in women with breast cancer≥70 years old?
10.1016/j.clbc.2024.05.002 · 2024
Is it wise to omit sentinel node biopsy in elderly patients with breast cancer?
10.1245/s10434-020-08759-1 · 2021
The association between surgical axillary staging adjuvant treatment use and survival in older women with early stage breast cancer: a population-based study
10.1245/s10434-023-13274-0 · 2023
Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer
10.1186/s12957-019-1585-9 · 2019
Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
10.1186/s40880-019-0371-y · 2019
Sentinel node biopsy should not be routine in older patients with ER-positive HER2-negative breast cancer who are willing and able to take hormone therapy
10.1245/s10434-021-09839-6 · 2021
Not performing a sentinel node biopsy for older patients with early-stage invasive breast cancer
10.1001/jamasurg.2015.0647 · 2015
Predicting survival benefit of sparing sentinel lymph node biopsy in low-risk elderly patients with early breast cancer: a population-based analysis
2020
Luminal A versus B after choosing wisely: does lymph node surgery affect oncologic outcomes?
10.1245/s10434-023-14485-1 · 2024
Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study
10.1016/j.ejso.2021.02.027 · 2021
A prospective study of sentinel node biopsy omission in women age≥65 years with ER+ breast cancer
10.1245/s10434-024-15000-w · 2024
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
10.1016/s1470-2045(14)70460-7 · doi-reference
Trends in breast cancer treatment de-implementation in older patients with hormone receptor-positive breast cancer: a mixed methods study
10.1245/s10434-020-08823-w · doi-reference
Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review
10.1007/s10549-014-2846-5 · doi-reference
A scoping review characterizing “Choosing Wisely®” recommendations for breast cancer management
10.1007/s10549-020-06009-2 · doi-reference
Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98)
10.1002/cncr.28499 · doi-reference
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93
10.1200/jco.2005.01.5784 · doi-reference
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
10.1016/s1470-2045(14)71221-5 · doi-reference
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343
10.1200/jco.2012.45.2615 · doi-reference
Clinical outcomes in early breast cancer with a high 21-gene recurrence score of 26 to 100 assigned to adjuvant chemotherapy plus endocrine therapy: a secondary analysis of the TAILORx randomized clinical trial
10.1001/jamaoncol.2019.4794 · doi-reference
21-gene assay to inform chemotherapy benefit in node-positive breast cancer
10.1056/nejmoa2108873 · doi-reference
Is axillary staging obsolete in early breast cancer?
10.1016/j.soc.2023.05.002 · doi-reference
How often do sentinel lymph node biopsy results affect adjuvant therapy decisions among postmenopausal women with early-stage HR+/HER2− breast cancer in the post-RxPONDER era?
10.1245/s10434-022-12193-w · doi-reference
No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial
10.1186/s12885-022-09273-1 · doi-reference
Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase ii trial
10.20892/j.issn.2095-3941.2022.0085 · doi-reference
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)
10.1186/s12885-017-3443-x · doi-reference
Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: a systematic review and meta-analysis
10.1016/j.jgo.2016.12.003 · doi-reference
A prospective study of sentinel node biopsy omission in women age≥65 years with ER+ breast cancer
10.1245/s10434-024-15000-w · doi-reference
Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study
10.1016/j.ejso.2021.02.027 · doi-reference
Luminal A versus B after choosing wisely: does lymph node surgery affect oncologic outcomes?
10.1245/s10434-023-14485-1 · doi-reference
Not performing a sentinel node biopsy for older patients with early-stage invasive breast cancer
10.1001/jamasurg.2015.0647 · doi-reference
Sentinel node biopsy should not be routine in older patients with ER-positive HER2-negative breast cancer who are willing and able to take hormone therapy
10.1245/s10434-021-09839-6 · doi-reference
Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
10.1186/s40880-019-0371-y · doi-reference
Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer
10.1186/s12957-019-1585-9 · doi-reference
The association between surgical axillary staging adjuvant treatment use and survival in older women with early stage breast cancer: a population-based study
10.1245/s10434-023-13274-0 · doi-reference
Is it wise to omit sentinel node biopsy in elderly patients with breast cancer?
10.1245/s10434-020-08759-1 · doi-reference
Does sentinel lymph node biopsy influence subsequent management decisions in women with breast cancer≥70 years old?
10.1016/j.clbc.2024.05.002 · doi-reference
(P05) Does sentinel lymph node biopsy impact systemic therapy recommendations?
10.1016/j.ijrobp.2018.02.093 · doi-reference
Impact of sentinel lymph node biopsy on treatment decision and survival in patients aged≥70 years with breast cancer: a retrospective study
10.1177/15330338221137216 · doi-reference
The role of sentinel lymph node biopsy in planning adjuvant therapy for elderly women with low-risk breast cancer
10.1111/tbj.13577 · doi-reference
Can we successfully de-escalate axillary surgery in women aged≥70 years with ductal carcinoma in situ or early-stage breast cancer undergoing mastectomy?
10.1245/s10434-021-11140-5 · doi-reference
Nodal staging affects adjuvant treatment choices in elderly patients with clinically node-negative estrogen receptor-positive breast cancer
10.3747/co.27.6515 · doi-reference
Outcomes after sentinel lymph node biopsy and radiotherapy in older women with early-stage estrogen receptor-positive breast cancer
10.1001/jamanetworkopen.2021.6322 · doi-reference
Long-term outcome of pT1a-b, cN0 breast cancer without axillary dissection or staging: a prospective observational study of 1543 women
10.1002/bjs.11610 · doi-reference
Omission of radiotherapy in women>60 years old after breast conserving surgery for breast cancer is non-inferior in terms of local recurrence: a retrospective cohort study
10.4274/ejbh.galenos.2023.2023-9-5 · doi-reference
Omitting radiotherapy is safe in breast cancer patients≥70 years old after breast-conserving surgery without axillary lymph node operation
10.1038/s41598-020-76663-5 · doi-reference
Axillary surgery in breast cancer - Primary results of the INSEMA trial
10.1056/nejmoa2412063 · doi-reference
Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the sound randomized clinical trial
10.1001/jamaoncol.2023.3759 · doi-reference
The role of routine sentinel lymph node biopsy in elderly patients with breast cancer
10.1016/j.ejso.2022.03.094 · doi-reference
Axillary staging is not justified in postmenopausal clinically node-negative women based on nodal disease burden
10.1245/s10434-022-12203-x · doi-reference
Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer
10.1002/cncr.32668 · doi-reference